Atara Biotherapeutics (ATRA) has potential for big investment returns! It’s the cure for MS!!

There's finally hope for people suffering with multiple sclerosis! A new research company Atara Biotherapeutics (ATRA) is in clinical trials for a new therapy, not a drug, that not only stops the progression of the disease but reverses the damage. In fact people in phase 1 were noted to improve their walking abilities. The discovery is that Epstein Bar Virus EBV is the cause of multiple sclerosis. Findings show >85% of the participants showed improvement in their condition over existing drugs in the market currently. Phase 2 just started and they expect big things to come. Follow this clinical trial by Googling “EMBOLD – ATA188” or follow the stock on Nasdaq (ATRA) for press releases. We have hope yet, for something closest to the cure EVER!